Cargando…

Hydralazine augmented ultrasound hyperthermia for the treatment of hepatocellular carcinoma

This study investigates the use of hydralazine to enhance ultrasound hyperthermia for the treatment of hepatocellular carcinoma (HCC) by minimizing flow-mediated heat loss from the tumor. Murine HCC tumors were treated with a continuous mode ultrasound with or without an intravenous administration o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karmacharya, Mrigendra B., Sultan, Laith R., Hunt, Stephen J., Sehgal, Chandra M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324788/ https://www.ncbi.nlm.nih.gov/pubmed/34330960 http://dx.doi.org/10.1038/s41598-021-94323-0

Ejemplares similares

Subsequent Ultrasound Vascular Targeting Therapy of Hepatocellular Carcinoma Improves the Treatment Efficacy
por: Sultan, Laith R., et al.
Publicado: (2021)

Photoacoustic monitoring of oxygenation changes induced by therapeutic ultrasound in murine hepatocellular carcinoma
por: Karmacharya, Mrigendra B., et al.
Publicado: (2021)

Microbubble-enhanced ultrasound for the antivascular treatment and monitoring of hepatocellular carcinoma
por: D'Souza, Julia C., et al.
Publicado: (2019)

4267 Noninvasive hybrid ultrasound and photoacoustic imaging for the assessment of liver fibrosis
por: Sultan, Laith Riyadh, et al.
Publicado: (2020)

Ultrasound Radiomics for the Detection of Early-Stage Liver Fibrosis
por: Al-Hasani, Maryam, et al.
Publicado: (2022)

2167 Beyond diagnosis: Using ultrasound to affect tumor vasculature for hepatocellular carcinoma (HCC) therapy
por: D’Souza, Julia, et al.
Publicado: (2018)

Can Sequential Images from the Same Object Be Used for Training Machine Learning Models? A Case Study for Detecting Liver Disease by Ultrasound Radiomics
por: Sultan, Laith R., et al.
Publicado: (2022)

Photoacoustic Imaging for Assessing Tissue Oxygenation Changes in Rat Hepatic Fibrosis
por: Karmacharya, Mrigendra B., et al.
Publicado: (2020)

A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19
por: Sultan, Laith R., et al.
Publicado: (2020)

Hydralazine-Induced Vasculitis
por: Gandhi, Pulkit, et al.
Publicado: (2023)

Combined Hyperthermia and Radiation Therapy for Treatment of Hepatocellular Carcinoma
por: Talaat, Roba M, et al.
Publicado: (2019)

Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
por: Zuckerman, Roman, et al.
Publicado: (2018)

B-mode ultrasound for the assessment of hepatic fibrosis: a quantitative multiparametric analysis for a radiomics approach
por: D’Souza, Julia C., et al.
Publicado: (2019)

Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
por: Strubchevska, Kateryna, et al.
Publicado: (2023)

Non-Invasive Radiofrequency-Induced Targeted Hyperthermia for the Treatment of Hepatocellular Carcinoma
por: Raoof, Mustafa, et al.
Publicado: (2011)

Hydralazine-Induced Vasculitis With Gastrointestinal Pseudomelanosis
por: Novikov, Aleksey, et al.
Publicado: (2014)

Clinical Characteristics of Hydralazine-induced Lupus
por: Timlin, Homa, et al.
Publicado: (2019)

Hydralazine-Induced Isolated Lupus Nephritis
por: Khan, Naseer, et al.
Publicado: (2020)

Focused Ultrasound Hyperthermia Augments Release of Glioma-derived Extracellular Vesicles with Differential Immunomodulatory Capacity
por: Sheybani, Natasha D., et al.
Publicado: (2020)

Quantitative pleural line characterization outperforms traditional lung texture ultrasound features in detection of COVID‐19
por: Sultan, Laith R., et al.
Publicado: (2021)

Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
por: Al‐Mohammad, Abdallah
Publicado: (2019)

Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
por: Bibby, M. C., et al.
Publicado: (1992)

Anti-neoplastic properties of hydralazine in prostate cancer
por: Graça, Inês, et al.
Publicado: (2014)

Hydralazine target: From blood vessels to the epigenome
por: Arce, Claudia, et al.
Publicado: (2006)

ANA-Negative Hydralazine-Induced Pericardial Effusion
por: Zeitjian, Vicken, et al.
Publicado: (2017)

Hydralazine-induced vasculitis presenting with ocular manifestations
por: Hawn, Vivian S., et al.
Publicado: (2022)

Can Artificial Intelligence Aid Diagnosis by Teleguided Point-of-Care Ultrasound? A Pilot Study for Evaluating a Novel Computer Algorithm for COVID-19 Diagnosis Using Lung Ultrasound
por: Sultan, Laith R., et al.
Publicado: (2023)

Observer Variability in BI-RADS Ultrasound Features and Its Influence on Computer-Aided Diagnosis of Breast Masses
por: Sultan, Laith R., et al.
Publicado: (2015)

Color Doppler Ultrasound Improves Machine Learning Diagnosis of Breast Cancer
por: Moustafa, Afaf F., et al.
Publicado: (2020)

Response to Hydralazine-Valproate in a Patient with Mycosis Fungoides
por: Dueñas-Gonzalez, Alfonso, et al.
Publicado: (2010)

The mechanism of hydralazine-induced collagen biosynthesis in cultured fibroblasts
por: Karna, Ewa, et al.
Publicado: (2013)

Anti-TNF-α and hydralazine drug-induced lupus
por: Quaresma, Maria Victória, et al.
Publicado: (2015)

Comparison of Hydralazine and Labetalol to lower severe hypertension in pregnancy
por: Khan, Ayesha, et al.
Publicado: (2017)

Acute Low-Dose Hydralazine-Induced Lupus Pneumonitis
por: Holman, Sarah K., et al.
Publicado: (2017)

Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer
por: Lopes, Nair, et al.
Publicado: (2021)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
por: Khosla, Atulya Aman, et al.
Publicado: (2023)

Hydralazine-Induced Lupus Syndrome Manifesting as Large Pericardial Effusion
por: Wilson, Nathaniel R, et al.
Publicado: (2020)

Hydralazine-Induced Lupus Presenting With Pancytopenia: A Case Report
por: Brar, Yudhveer, et al.
Publicado: (2022)

Augmentation in Chemosensitivity of Intratumor Quiescent Cells by Combined Treatment with Nicotinamide and Mild Hyperthermia
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1997)

Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
por: Stratford, I. J., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_hn9krlhfnfj4eei8sk1aghcuvu